With the analysis among 1,542 patents, we discovered top 472 key players by total patent application. Guangzhou SALIAI Stemcell Science & Technology Co., Ltd., Life Technologies Corp., Smithkline Beckman Corp are dominant in this area. They take 4.86% of the total patent filing.
Guangzhou SALIAI Stemcell Science & Technology Co., Ltd.
Guangdong Sheng, China
Patent: 39
California, United States
Patent: 18
Pennsylvania, United States
Patent: 18
AbbVie Biotherapeutics, Inc.
Illinois, United States
Patent: 18
Tokyo-to, Japan
Patent: 16
Mitsubishi Tanabe Pharma Corp.
Osaka-fu, Japan
Patent: 14
Foshan Golden Blue Collar Education Technology Co., Ltd.
Guangdong Sheng, China
Patent: 14
Bayer Healthcare Co., Ltd.
Beijing Shi, China
Patent: 13
With the analysis among 15 patents, we discovered top 8 start-ups by total patent application. Nextphase Therapeutics, Inc., Institut National de la Santé et de la Recherche Médicale, Chongqing TCRCure Biological Technology Co., Ltd. are active in this area.
Nextphase Therapeutics, Inc.
Washington, United States
Patent: 6
Institut National de la Santé et de la Recherche Médicale
Chongqing TCRCure Biological Technology Co., Ltd.
Chongqing Shi, China
Patent: 1
Texas, United States
Patent: 1
optoLANE Technologies, Inc.
Gyeonggi-do, South Korea
Patent: 1
CMAB BioPharma (Suzhou) Inc.
Jiangsu Sheng, China
Patent: 1
With the analysis among related 786 patents applied in the last 5 years. We discover 478 most active companies in this area. The fast-growing Guangzhou SALIAI Stemcell Science & Technology Co., Ltd., Guangdong Guoke Cell Technology Co., Ltd., Suzhou ExCell Biological Technology Co., Ltd. take 3.82% of patent filing during this period.
Guangzhou SALIAI Stemcell Science & Technology Co., Ltd.
Guangdong Sheng, China
Patent: 11
Guangdong Guoke Cell Technology Co., Ltd.
Guangdong Sheng, China
Patent: 10
Suzhou ExCell Biological Technology Co., Ltd.
Jiangsu Sheng, China
Patent: 9
iRegene Therapeutics Co.,Ltd
Hubei Sheng, China
Patent: 9
Chuangxin International Biotechnology Guangzhou Co. Ltd.
Guangdong Sheng, China
Patent: 8
Washington, United States
Patent: 8
Zhejiang Sheng, China
Patent: 8
Kunming University of Science & Technology
Yunnan Sheng, China
Patent: 8
Guangzhou Regenerative Medicine and Health Guangdong Laboratory
undefined undefined
Patent: 8
With the analysis among related 786 patents in last 5 years, we discover 401 new entrants. Guangdong Guoke Cell Technology Co., Ltd., Suzhou ExCell Biological Technology Co., Ltd., iRegene Therapeutics Co.,Ltd are the most active new entrants in this area.
Guangdong Guoke Cell Technology Co., Ltd.
Guangdong Sheng, China
Patent: 10
Suzhou ExCell Biological Technology Co., Ltd.
Jiangsu Sheng, China
Patent: 9
iRegene Therapeutics Co.,Ltd
Hubei Sheng, China
Patent: 9
Chuangxin International Biotechnology Guangzhou Co. Ltd.
Guangdong Sheng, China
Patent: 8
Washington, United States
Patent: 8
Kunming University of Science & Technology
Yunnan Sheng, China
Patent: 8
Guangzhou Regenerative Medicine and Health Guangdong Laboratory
undefined undefined
Patent: 8
Agency for Science, Technology & Research
Central Region, Singapore
Patent: 7
Hangzhou Aiming Medical Technology Co. Ltd.
Zhejiang Sheng, China
Patent: 6
Nextphase Therapeutics, Inc.
Washington, United States
Patent: 6
With the analysis among 677 patents, we discovered top 191 universities and scientific research institutions by total patent application. Zhejiang University, Council of Scientific & Industrial Research, Beijing Normal University are dominant in this area. They take 7.98% of the total patent filing.
Zhejiang Sheng, China
Patent: 16
Council of Scientific & Industrial Research
Beijing Normal University
Beijing Shi, China
Patent: 12
East China University of Science & Technology
Shanghai Shi, China
Patent: 9
Sichuan Agricultural University
Sichuan Sheng, China
Patent: 8
Kunming University of Science & Technology
Yunnan Sheng, China
Patent: 8
Beijing Shi, China
Patent: 7
Fujian Sheng, China
Patent: 6
Guangdong Sheng, China
Patent: 5
Beijing Shi, China
Patent: 5